首页> 美国卫生研究院文献>other >Cost-Effectiveness Analysis: a proposal of new reporting standards in statistical analysis
【2h】

Cost-Effectiveness Analysis: a proposal of new reporting standards in statistical analysis

机译:成本效益分析:有关统计分析的新报告标准的建议

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Cost-effectiveness analysis (CEA) is a method for evaluating the outcomes and costs of competing strategies designed to improve health, and has been applied to a variety of different scientific fields. Yet, there are inherent complexities in cost estimation and CEA from statistical perspectives (e.g., skewness, bi-dimensionality, and censoring). The incremental cost-effectiveness ratio that represents the additional cost per one unit of outcome gained by a new strategy has served as the most widely accepted methodology in the CEA. In this article, we call for expanded perspectives and reporting standards reflecting a more comprehensive analysis that can elucidate different aspects of available data. Specifically, we propose that mean and median-based incremental cost-effectiveness ratios and average cost-effectiveness ratios be reported together, along with relevant summary and inferential statistics as complementary measures for informed decision making.
机译:成本效益分析(CEA)是一种评估旨在改善健康状况的竞争策略的结果和成本的方法,并且已应用于各种不同的科学领域。然而,从统计的角度来看,成本估算和CEA存在固有的复杂性(例如,偏度,二维和审查)。成本效益比的增量代表了一项新策略所获得的每单位结果的额外成本,已成为CEA中最广泛接受的方法。在本文中,我们要求扩展视角和报告标准,以反映更全面的分析,从而可以阐明可用数据的不同方面。具体来说,我们建议将基于均值和中位数的增量成本—效果比和平均成本—效果比,以及相关的摘要和推论统计数据一起报告,以作为明智决策的补充措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号